A real-world disproportionality analysis of anti-VEGF drugs from the FDA Adverse Event Reporting System

CONCLUSIONS: Our findings support the associations between anti-VEGF drugs and ocular AEs, cardiac AEs, and central nervous AEs. After intravitreal injection, attention should not only be paid to ocular symptoms, but also to systemic symptoms.PMID:37665052 | DOI:10.1080/14740338.2023.2250717

Source: Expert Opinion on Drug Safety - September 4, 2023 Category: Drugs & Pharmacology Authors: Ruishan Zhou Peiwen Lu Mingxiu He Junheng Chen Yiyang Shi Fangfang Han Yongming Cai Source Type: research